This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Seasonal Affective Disorder Therapeutics Market

Market Insights on Seasonal Affective Disorder Therapeutics covering sales outlook, demand forecast & up-to-date key trends

Seasonal Affective Disorder Therapeutics Market By Treatment Type (Drugs, Devices), Disorder Type (Unipolar Disorders, Bipolar Disorders), Distribution Channel (Institutional Sales, Retail Sales) & Region - Forecast 2022 - 2028

Seasonal Affective Disorder Therapeutics Market Outlook (2022-2028)

[216 Pages] From 2022 to 2028, the global seasonal affective disorder therapeutics market is slated to rise at a CAGR of 4.3%. Currently, the market accounts for a valuation of US$ 848.2 Mn, and is projected to close in on US$ 1.1 Bn by the end of 2028.

Seasonal Affective Disorder Therapeutics Market Size (2022)

US$ 848.2 Mn

Projected Market Value (2028)

US$ 1.1 Bn

Global Market Growth Rate (2022-2028)

4.3% CAGR

North America Market Share

38.4%

Sales of seasonal affective disorder therapeutic drugs and devices account for a share of 4.6% in the global depressive disorder treatment market. Preference and popularity of bright light therapy among physicians and patients is expected to be a major trend driving seasonal affective disorder therapeutics demand growth through 2028.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

4.29%

H1, 2022 Projected

4.34%

H1, 2022 Outlook

4.24%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 05 ↓

The market for seasonal affective disorder therapeutics is subject to change as per the regulatory dynamics for drugs, in accordance to macroeconomic and industrial standards.

The variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 10 BPS units. Additionally, a drop in BPS growth in H1-2022 over H1-2021 by 05 Basis Point Share (BPS) is demonstrated by the market.

The decline in the BPS values is associated with the limited evidence for the effectiveness of light therapy when compared with other available preventive options. Moreover, patient preference towards treatment modalities is dominant for the preventive treatment of seasonal affective disorder.

On the contrary, the market is expected to gain traction in terms of growth and sales outlook during the forecast period. This is supported with the development of second-generation antidepressants for the treatment of seasonal affective disorder in adults.

The key developments in the market include the FDA approval of an extended-release antidepressant, bupropion, for the prevention of recurrent seasonal affective disorder with major depressive episodes.

Demand Survey of Seasonal Affective Disorder Therapeutics (2013 to 2021) Vs Market Statistics (2022 to 2028)

Anxiety and depression among the general population have seen a substantial spike over the past few years and this has majorly influenced the healthcare industry in multiple ways. The seasonal affective disorder therapeutics market exhibited expansion at a CAGR of 3.7% from 2013 to 2021.

Increasing prevalence of seasonal affective disorders, rising instances of depression among the general population, increasing availability of treatment options, and rising research and development activities in therapeutics are some major factors that are anticipated to influence seasonal affective disorder therapeutics demand over the forecast period.

Research & development activities are of paramount importance in helping create effective therapeutic solutions for seasonal affective disorders. Seasonal affective disorder therapeutic providers are focusing on expanding their research scope and creating novel therapeutic solutions for patients.

  • For instance, in April 2021, researchers at the Indiana University School of Medicine published a new study that indicates promising results of blood tests to detect bipolar disorders and depression. This study, led by Dr. Alexander B. Niculescu, is expected to offer a promising scope of precision medicine and personalized treatment for patients.

Seasonal Affective Disorder Therapeutics Market Download Report Brochure

Demand for seasonal affective disorder therapeutics is estimated to rise at a CAGR of 4.3% from 2022 to 2028.

What Market Factors Could Seasonal Affective Disorder Therapeutic Providers Benefit From?

“Increasing Popularity of Light Therapy to Positively Impact Market Potential”

Bright light therapy has emerged as one of the most popular aspects of the seasonal affective disorder therapeutics marketplace in recent years. This therapy provides a rapid anti-depressant effect on patients and has seen an increase in recommendation by physicians and health professionals.

  • For instance, in July 2021, researchers at the University of Fribourg published a study in the PLOS Genetics journal and depicted effects of light therapy on depression in mice models. Activation of circadian clock gene Period1 in the mood-affecting region of the brain was found to help treat depression, in this study by Urs Albrecht.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is Negatively Affecting Demand for Seasonal Affective Disorder Therapeutic Devices?

“Lack of Research Data & Adverse Effects of Anti-depressants to Majorly Hamper Market Growth”

Scarce research data and low availability of information on seasonal affective disorders are anticipated to be major barriers for seasonal affective disorder therapeutics providers. Inadequate research data on effects of bright light and blue light on the treatment of patients is expected to restrain market potential.

Adverse effects associated with excessive use of anti-depressants and other therapy drugs are predicted to be a major issue in the seasonal affective disorder therapeutics industry landscape over the forecast period.

What is the Regional Outlook for Seasonal Affective Disorder Therapeutic Companies?

“North America to Exhibit Highly Lucrative Opportunities through 2028”

Statistical analysis of seasonal affective disorder therapeutics market metrics for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been assessed in this market study.

Accounting for a dominative market share of 38.4% in the global seasonal affective disorder therapeutics marketplace, North America is anticipated to provide a highly beneficial setting for seasonal affective disorder therapeutic companies. Increasing prevalence of seasonal affective disorders and rising focus on healthcare are expected to be major trends in this region.

Second to North America, the Europe seasonal affective disorder therapeutics product market accounts for a market share of 29.5% in 2022. Increasing healthcare expenditure and rising research and development activities for seasonal affective disorders are expected to be prominent trends in this region through 2028.

Rising awareness about anxiety and depression is expected to majorly boost awareness about seasonal affective disorders in regions of East Asia and South Asia. Currently, East Asia and South Asia account for market shares of 18.5% and 7.5% in the global seasonal affective disorder therapeutics market.

Lack of awareness, low research activity, and underdeveloped healthcare infrastructure are expected to lead to slow growth in seasonal affective disorder therapeutics demand in regions of Oceania and the MEA. At present, the MEA and Oceania regions hold market shares of 1.5% and 1%, respectively, in the global seasonal affective disorder therapeutics industry.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

What is the Outlook for Seasonal Affective Disorder Therapeutic Device Manufacturers in India?

“Rising Awareness & Focus on Mental Health Expected to Positively Impact Market Expansion”

Mental health has emerged as one of the most concerning healthcare issues in India over the past few years and this has also bolstered demand for multiple seasonal affective disorder treatments. Developing healthcare infrastructure, lack of awareness, and lack of availability of treatments are expected to be prominent trends controlling demand for seasonal affective disorder therapeutics in India.

How Will the U.S. Seasonal Affective Disorder Therapeutics Market Fare?

“High Prevalence of Multiple Seasonal Affective Disorders to Positively Influence Demand”

The U.S. has seen a substantial increase in instances of anxiety and depression-related disorders and this has fostered a demand for seasonal affective disorder therapeutics. Rising instances of bipolar disorders is the major trend that drives the market potential for this nation.

High research & development activities and increasing availability of treatment options are also expected to favor seasonal affective disorder therapeutics demand.

Seasonal affective disorder therapeutic providers are focusing on developing and launching novel treatment solutions to maximize their revenue potential in the nation.

Category-wise Analysis

What Influence Does Bipolar Disorder Have on This Market?

“High Incidence of Bipolar Disorders to Majorly Govern Seasonal Affective Disorder Therapeutics Demand”

Bipolar disorder has emerged as one of the most prominent seasonal affective disorders over recent years and this has led to its substantial influence on the seasonal affective disorder therapeutics marketplace.

This disorder is expected to hold a dominant market share over the forecast period and is expected to be a majorly influential segment through 2028.

COVID-19 Impact Survey

The unexpected and sudden emergence of the COVID-19 pandemic adversely affected the mental health of people all over the globe and led to an increase in anxiety and depression in individuals.

While the seasonal affective disorder therapeutics market saw a negative growth trend in 2020 due to disruptions to supply chains and lockdown mandates, the seasonal affective disorder therapeutics market is expected to see high demand in the post-pandemic era.

Competitive Landscape

Seasonal affective disorder therapeutic providers are investing in the research & development of novel therapeutics specific to seasonal affective disorders. Seasonal affective disorder therapeutic equipment manufacturing companies are also adopting organic and inorganic strategies to increase awareness about seasonal affective disorders and boost their sales revenue.

  • For instance, in December 2021, the U.S. Food and Drug Administration (FDA) cleared a new drug that would be used in treating bipolar depression. The drug Caplyta (lumateperone) created by a pharmaceutical company called Intra-Cellular Therapies, has been approved to treat depressive episodes that are resulted from bipolar I or bipolar II disorders in adults.

As it is the first FDA-approved drug of its kind, it is expected to see high demand over the coming years.

Seasonal Affective Disorder Therapeutics Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Treatment Type
  • Disorder Type
  • Distribution Channel
  • Region

Key Companies Profiled

  • Allergan plc.
  • Eli Lily Company
  • GlaxoSmithKline
  • Pfizer Inc.
  • Teva Pharmaceuticals
  • Bausch Health Companies Inc.
  • F. Hoffman-La Roche AG
  • Mylan N.V.
  • Sanofi AG
  • Novartis AG
  • Janssen Pharmaceuticals Inc.
  • Koninklije Philips N.V.
  • The Sunbox Company
  • Beurer GmbH
  • Lucimed S.A.

Pricing

Available upon Request

Key Segments of Seasonal Affective Disorder Therapeutics Industry Survey

Seasonal Affective Disorder Therapeutics Market by Treatment Type:

  • Seasonal Affective Disorder Therapeutic Drugs
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
    • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
    • Monoamine Oxidase Inhibitors (MAOIs)
    • Tricyclic Antidepressants (TCAs)
  • Seasonal Affective Disorder Therapeutic Devices
    • Light Boxes
    • Dawn Stimulators
    • Desk Lamps
    • Sun Visors

Seasonal Affective Disorder Therapeutics Market by Disorder Type:

  • Seasonal Affective Disorder Therapeutics for Unipolar Disorders
    • Fall-Winter Onset
    • Spring-Summer Onset
  • Seasonal Affective Disorder Therapeutics for Bipolar Disorders

Seasonal Affective Disorder Therapeutics Market by Distribution Channel:

  • Institutional Sales
    • Seasonal Affective Disorder Therapeutics for Hospitals
    • Seasonal Affective Disorder Therapeutics for Clinics
    • Seasonal Affective Disorder Therapeutics for Wellness Centres & Spas
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Online Sales

Seasonal Affective Disorder Therapeutics Market by Region:

  • North America Seasonal Affective Disorder Therapeutics Market
  • Latin America Seasonal Affective Disorder Therapeutics Market
  • Europe Seasonal Affective Disorder Therapeutics Market
  • East Asia Seasonal Affective Disorder Therapeutics Market
  • South Asia & Pacific Seasonal Affective Disorder Therapeutics Market
  • Middle East & Africa (MEA) Seasonal Affective Disorder Therapeutics Market

Frequently Asked Questions

The global seasonal affective disorder therapeutics market is anticipated to attain a valuation of US$ 1.1 Bn by the end of 2028.

Key suppliers of seasonal affective disorder therapeutic systems are F. Hoffman-La Roche AG, Mylan N.V., Sanofi AG, Novartis AG, Janssen Pharmaceuticals Inc., Koninklije Philips N.V., and The Sunbox Company.

Currently, the North America seasonal affective disorder therapeutics market holds a prominent share of 38.4% in the global industry.

From 2022 to 2028, the seasonal affective disorder therapeutics market is predicted to expand at a CAGR of 4.3%.

In 2022, the seasonal affective disorder therapeutics market accounts for a value of US$ 848.2 Mn.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Macro-Economic Factors

    3.2. Forecast Factors - Relevance & Impact

    3.3. Market Dynamics

            3.3.1. Drivers

            3.3.2. Restraints

            3.3.3. Opportunities

            3.3.4. Trends

4. Key Success Factors

    4.1. Key Regulations

    4.2. Disease Epidemiology

5. Global Seasonal Affective Disorder Therapeutics Market Volume Analysis 2013-2021 and Forecast, 2022-2028

    5.1. Historical Market Volume (‘000 Units) Analysis, 2013-2021

    5.2. Current and Future Market Volume (‘000 Units) Projections, 2022-2028

6. Global Seasonal Affective Disorder Therapeutics Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Device Type

    6.2. Global Average Pricing Analysis Benchmark

7. Global Seasonal Affective Disorder Therapeutics Market Value Analysis 2013-2021 and Forecast, 2022-2028

    7.1. Historical Market Value (US$ Mn) Analysis, 2013-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028

            7.2.1. Y-o-Y Growth Trend Analysis

            7.2.2. Absolute $ Opportunity Analysis

8. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Treatment Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013 - 2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2022 – 2022

            8.3.1. Drugs

                    8.3.1.1. Selective serotonin reuptake inhibitors (SSRIs)

                    8.3.1.2. Norepinephrine-dopamine reuptake inhibitor (NDRI)

                    8.3.1.3. Serotonin and norepinephrine reuptake inhibitors (SNRIs)

                    8.3.1.4. Monoamine oxidase inhibitors (MAOIs)

                    8.3.1.5. Tricyclic antidepressants (TCAs)

            8.3.2. Devices

                    8.3.2.1. Light Boxes

                    8.3.2.2. Dawn Stimulators

                    8.3.2.3. Desk Lamps

                    8.3.2.4. Sun Visors

    8.4. Market Attractiveness Analysis By Treatment Type

9. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Disorder Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Disorder Type, 2013 - 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disorder Type, 2022 - 2022

            9.3.1. Unipolar Disorder

                    9.3.1.1. Fall-winter onset

                    9.3.1.2. Spring-summer onset

            9.3.1.2. Bipolar Disorder

    9.4. Market Attractiveness Analysis By Sales Channel

10. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2022

            10.3.1. Institutional Sales

                    10.3.1.1. Hospitals

                    10.3.1.2. Clinics

                    10.3.1.3. Wellness Centers & Spas

            10.3.2. Retail Sales

                    10.3.2.1. Retail Pharmacies

                    10.3.2.2. Drug Stores

                    10.3.2.3. Online Sales

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2022

            11.3.1. North America

            11.3.2. Latin America

            11.3.3. Europe

            11.3.4. Middle East and Africa (MEA)

            11.3.5. East Asia

            11.3.6. South Asia

            11.3.7. Oceania

    11.4. Market Attractiveness Analysis By Region

12. North America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            12.3.1. By Country

                    12.3.1.1. U.S.

                    12.3.1.2. Canada

            12.3.2. By Treatment Type

            12.3.3. By Disorder Type

            12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

13. Latin America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            13.3.1. By Country

                    13.3.1.1. Brazil

                    13.3.1.2. Mexico

                    13.3.1.3. Argentina

                    13.3.1.4. Rest of Latin America

            13.3.2. By Treatment Type

            13.3.3. By Disorder Type

            13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

14. Europe Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            14.3.1. By Country

                    14.3.1.1. Germany

                    14.3.1.2. Italy

                    14.3.1.3. France

                    14.3.1.4. U.K.

                    14.3.1.5. Spain

                    14.3.1.6. Russia

                    14.3.1.7. Rest of Europe

            14.3.2. By Treatment Type

            14.3.3. By Disorder Type

            14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

15. South Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            15.3.1. By Country

                    15.3.1.1. India

                    15.3.1.2. Thailand

                    15.3.1.3. Indonesia

                    15.3.1.4. Malaysia

                    15.3.1.5. Rest of South Asia

            15.3.2. By Treatment Type

            15.3.3. By Disorder Type

            15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

16. East Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            16.3.1. By Country

                    16.3.1.1. China

                    16.3.1.2. Japan

                    16.3.1.3. South Korea

            16.3.2. By Treatment Type

            16.3.3. By Disorder Type

            16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

17. Oceania Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            17.3.1. By Country

                    17.3.1.1. Australia

                    17.3.1.2. New Zealand

            17.3.2. By Treatment Type

            17.3.3. By Disorder Type

            17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

18. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028

            18.3.1. By Country

                    18.3.1.1. GCC Countries

                    18.3.1.2. South Africa

                    18.3.1.3. Rest of Middle East and Africa

            18.3.2. By Treatment Type

            18.3.3. By Disorder Type

            18.3.4. By Distribution Channel

   18.4. Market Attractiveness Analysis

19. Emerging Countries Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028

    19.1. Introduction

            19.1.1. Market Value Proportion Analysis, By Key Countries

            19.1.2. Global Vs. Country Growth Comparison

    19.2. China Seasonal Affective Disorder Therapeutics Market Analysis

            19.2.1. Introduction

            19.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

                    19.2.2.1. By Treatment Type

                    19.2.2.2. By Disorder Type

                    19.2.2.3. By Distribution Channel

    19.3. Russia Seasonal Affective Disorder Therapeutics Market Analysis

            19.3.1. Introduction

            19.3.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

                    19.3.2.1. By Treatment Type

                    19.3.2.2. By Disorder Type

                    19.3.2.3. By Distribution Channel

    19.4. Indonesia Seasonal Affective Disorder Therapeutics Market Analysis

            19.4.1. Introduction

            19.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

                    19.4.2.1. By Treatment Type

                    19.4.2.2. By Disorder Type

                    19.4.2.3. By Distribution Channel

            19.4.3. Russia Seasonal Affective Disorder Therapeutics Market - Competition Landscape

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Deep Dive

            20.2.1. Allergan plc

                    20.2.1.1. Overview

                    20.2.1.2. Product Portfolio

                    20.2.1.3. Analyst Commentary

                    20.2.1.4. Key Financials

                    20.2.1.5. Strategy Overview

            20.2.2. Eli Lily Company

            20.2.3. GlaxoSmithKline

            20.2.4. Pfizer Inc.

            20.2.5. Teva Pharmaceuticals

            20.2.6. Bausch Health Companies Inc.

            20.2.7. F. Hoffmann-La Roche AG

            20.2.8. Mylan N.V.

                20.2.8.1. Sanofi AG

            20.2.9. Novartis AG

            20.2.10. Janssen Pharmaceuticals, Inc.

            20.2.11. Koninklijke Philips N.V

            20.2.12. The Sunbox Company

            20.2.13. Beurer GmbH

            20.2.14. Lucimed S.A.

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type

Table 02: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type

Table 03: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Disorder Type

Table 04: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Distribution Channel

Table 05: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region

Table 06: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 07: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 08: North America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 09: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 10: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 11: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 12: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 13: Latin America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 14: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 15: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 16: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 17: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 18: Europe Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 19: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 20: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 21: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 22: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 23: South Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 24: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 25: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 26: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 27: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 28: East Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 29: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 30: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 31: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 32: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 33: Oceania Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 34: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 35: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 36: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 37: Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 38: MEA Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 39: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 40: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 41: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 42: China Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 43: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 44: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 45: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 46: Russia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 47: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 48: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Table 49: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

Table 50: Indonesia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

Table 51: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

Table 52: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Seasonal Affective Disorder Therapeutics Market Volume Analysis (‘000 Units), By Devices, 2013-2017

Figure 02: Global Seasonal Affective Disorder Therapeutics Market Volume Forecast (‘000 Units), By Devices, 2018-2028

Figure 03: Light Boxes, Pricing Analysis per unit (US$), By Region, 2017

Figure 04: Light Boxes, Pricing Analysis per unit (US$), By Region, 2028

Figure 05: Dawn Stimulator, Pricing Analysis per unit (US$), By Region, 2017

Figure 06: Dawn Stimulator, Pricing Analysis per unit (US$), By Region, 2028

Figure 07: Desk Lamp, Pricing Analysis per unit (US$), By Region, 2017

Figure 08: Desk Lamp, Pricing Analysis per unit (US$), By Region, 2028

Figure 09: Sun Visors , Pricing Analysis per unit (US$), By Region, 2017

Figure 10: Sun Visors , Pricing Analysis per unit (US$), By Region, 2028

Figure 11: Global Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 12: Global Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 13: Global Seasonal Affective Disorder Therapeutics Market Absolute $ Opportunity, 2018 - 2028

Figure 14: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Treatment Type, 2018 & 2028

Figure 15: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Treatment Type, 2018-2028

Figure 16: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 17: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Disorder Type, 2018 & 2028

Figure 18: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Disorder Type, 2018-2028

Figure 19: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 20: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Distribution Channel, 2018 & 2028

Figure 21: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2028

Figure 22: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 23: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Region, 2018 & 2028

Figure 24: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Region, 2018-2028

Figure 25: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Region, 2018-2028

Figure 26: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 27: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 28: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 29: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 30: North America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 31: North America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 32: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 33: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 34: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 35: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 36: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 37: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 38: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 39: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 40: Latin America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 41: Latin America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 42: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 43: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 44: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 45: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 46: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 47: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 48: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 49: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 50: Europe Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 51: Europe Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 52: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 53: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 54: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 55: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 56: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 57: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 58: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 59: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 60: South Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 61: South Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 62: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 63: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 64: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 65: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 66: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 67: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 68: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 69: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 70: East Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 71: East Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 72: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 73: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 74: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 75: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 76: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 77: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 78: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 79: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 80: Oceania Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 81: Oceania Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 82: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 83: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 84: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 85: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 86: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

Figure 87: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

Figure 88: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

Figure 89: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

Figure 90: MEA Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 91: MEA Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 92: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

Figure 93: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

Figure 94: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

Figure 95: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

Figure 96: Global Seasonal Affective Disorder Therapeutics Market Value Proportion Analysis, By Emerging Countries, 2018

Figure 97: Seasonal Affective Disorder Therapeutics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2028

Figure 98: China Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 99: China Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 100: Russia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 101: Russia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Figure 102: Indonesia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

Figure 103: Indonesia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Prescription Delivery Services Market

Published : September 2020

Healthcare

Antibodies Market

Published : July 2021

Healthcare

Muscle Stimulation Devices Market

Published : December 2021

Healthcare

Clinical Trials Market

Published : July 2019

Google translate

Seasonal Affective Disorder Therapeutics Market